“You can stop a drug if it’s causing problems, but you can’t stop an operation. The problem with clinical trials in surgery is that it is a decisive, irreversible act. Surgeons aren’t natural clinical researchers, but all that is changing.”
EXPLORE: Join over 1000 clinical research professionals at PCT Europe in Vienna on 16 - 17 November 2016
As a cancer surgeon he was sure his methods were the best, but couldn’t convince his colleagues despite the number of lives he was saving: “The only way to show which was the best treatment was through clinical research, and the gold standard is the prospective randomised study.”
We spoke to Professor Hutchison about the challenges of clinical trials in surgery and the results they have seen in a mouth cancer study. Listen to the fascinating interview below.
- Integrating the Digital and Physical Supply Chain
- How the Cancer Moonshot Impacts Clinical Trial Opportunities for Rare Disease Patients
- WEBINAR: How can you best manage performance in an extended clinical research team?